Home
Early Phase Clinical Research Australia (EPCRA) is a consortium of leading Phase I clinical research sites around Australia. EPCRA enables Pharmaceutical and Biotech Sponsors access to hospital based principal investigators, individual researchers, medical schools, dedicated research precinct facilities and capabilities and experienced clinical research professionals for the conduct of early phase clinical trials.
- All units have successfully undergone regulatory and sponsor audits, including FDA
- The consortium covers all of the major population bases in Australia, allowing rapid recruitment into multi-site patient phase I trials
EPCRA comprises:
- CMAX- A division of IDT Limited (Adelaide, South Australia)
- GSK Medicines Research Unit (Sydney, New South Wales)
- Nucleus Network Ltd (Melbourne, Victoria)
- Q-Pharm Pty Ltd (Brisbane, Queensland)
11000000101010101111000011001100111111111010101011111111101000001000100011110000110011001010101010101010101010101111000011110000
|